Further study uncovered that bostrycin inhibits the proliferation of breast cancer cells through changing the structure of PTP1B (protein tyrosine phosphatase 1B) and inhibiting its activity (Dongni et al., 2013). The gene discussed is PTPN1; the disease is breast cancer.